Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bioventus (BVS) Long-Term Debt Issuances (2020 - 2025)

Bioventus (BVS) has disclosed Long-Term Debt Issuances for 5 consecutive years, with -$13.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$13.1 million, compared with a TTM value of $31.9 million through Dec 2025, changed N/A, and an annual FY2025 reading of $31.9 million, changed N/A over the prior year.
  • Long-Term Debt Issuances was -$13.1 million for Q4 2025 at Bioventus, down from $30.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $257.5 million in Q4 2021 and bottomed at -$54.7 million in Q4 2022.
  • Average Long-Term Debt Issuances over 4 years is $37.8 million, with a median of $15.0 million recorded in 2022.
  • The sharpest move saw Long-Term Debt Issuances soared 625.41% in 2021, then plummeted 121.23% in 2022.
  • Year by year, Long-Term Debt Issuances stood at $257.5 million in 2021, then plummeted by 121.23% to -$54.7 million in 2022, then surged by 127.44% to $15.0 million in 2023, then tumbled by 187.29% to -$13.1 million in 2025.
  • Business Quant data shows Long-Term Debt Issuances for BVS at -$13.1 million in Q4 2025, $30.0 million in Q3 2025, and $15.0 million in Q1 2025.